Acosamine and ristosamine derivatives were prepared via stereoselective reductive cleavage reactions of a benzylidenated dihydroisoxazolyl diol; the diol was prepared from 3-nitro-4,5dihydroisoxazole via sequential propynylation, Lindlar reduction, and catalytic hydroxylation.
Regioselective asymmetric aminohydroxylation of precursors to 2,3,6-trideoxy-3-aminohexoses
โ Scribed by Roger M Davey; Margaret A Brimble; Malcolm D McLeod *
- Book ID
- 104210484
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- French
- Weight
- 248 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
โฆ Synopsis
The catalytic asymmetric aminohydroxylation (AA) of 5-substituted-pent-2-enoates 8 and 17 was investigated as a route to 2,3,6-trideoxy-3-aminohexoses. The AA of ester 8, which bears a dimethyl acetal at C-5, favoured formation of the a-amino regioisomer 11 with optimum regioselectivity being observed using (DHQ) 2 AQN as the chiral ligand and the chloramine salt of ethyl carbamate as the nitrogen source. Ester 17, which has a 4-methoxyphenoxy group at C-5, undergoes highly regioselective AA aording the b-amino regioisomer 19 in excellent enantiomeric excess, thereby establishing that introduction of this aromatic group leads to a superior substrate for AA.
๐ SIMILAR VOLUMES
The synthesis of the N-benzoyi! derivatives of L-arabino ilO),L-xylo (13) and L-1~x0 -\_\_\_ (L=vancosamine) (12) 2,3,6-trideoxy-3-C\_methyl-3-minohexose from the (2g,3g) dioZ (1) prepared in fermenting bakers' yeast from cr-methyZcinnamaZdehyde and acetazdehyde is reported The 3-C-methyl branched a
The enantiomeric alcohols ( 2) and (g), obtained from (2!,3E) tartaric acid and, respectively, L-threonine, have been used to construct the C6, enantiomeric deoxy amino sugar derivatives ( 7) and ( 12) -
Ring-fluorinated b-hydroxy a-amino methyl esters 3b,c were synthesized enantioselectively using Sharpless asymmetric aminohydroxylation. These were converted to 2-fluoro-and 6-fluoro-(2S,3R)-threo-(3,4-dihydroxyphenyl)serine 1b,c using our previously published procedure.